21 May 2013
Keywords: newron, says, epo, issue, safinamide, patent, pd
Article | 03 March 2008
Italian R&D firm Newron Pharmaceuticals says that it has received a
written confirmation from the European Patent Office that ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 March 2008
20 May 2013
© 2013 thepharmaletter.com